[Los Angeles, Ca.] – October 18, 2017 Goldman Sachs (NYSE:GS) is recognizing Episource’s Co-CEOs as two of the 100 Most Intriguing Entrepreneurs of 2017 at its Builders + Innovators Summit in Santa Barbara, California.
Goldman Sachs selected Sishir Reddy and Harshith Ramesh, as two of 100 entrepreneurs from multiple industries to be honored at the two-day event. Sishir Reddy has extensive experience in healthcare leadership, including revenue cycle management and medical coding services, he has helped make Episource a leading provider of Payer-focused solutions. Sishir received a BA in Chemistry from Claremont Mckenna College and a MIS from the Claremont Graduate University. Harshith Ramesh’s background includes investment banking, focusing on M&A, restructuring, and capital markets assignments. He has worked for a range of global institutions, including Moelis & Co., Bain & Co., and Bear, Stearns & Co. Harshith earned his Bachelors at Tulane University, and an MBA from the Wharton School.
“We are pleased to recognize Sishir Reddy and Harshith Ramesh as two of the most intriguing entrepreneurs of 2017,” said David M. Solomon, President and Co-Chief Operating Officer at Goldman Sachs. “This is the sixth year that we’ve hosted the Builders + Innovators Summit where emerging business leaders gather to discuss their common interests in building prosperous organizations.”
For more than 145 years, Goldman Sachs has been advising and financing entrepreneurs as they launch and grow their businesses. In addition to honoring 100 entrepreneurs, the Summit consists of general sessions and clinics led by Goldman Sachs experts, seasoned entrepreneurs, academics and business leaders as well as resident scholars.
Episource is driven to collect data that’s insightful and accurate. With innovative technology and a global services model, our mission is to help Healthcare Payer and Provider Organizations meet their members’ needs in a way that results in better patient experience and health outcomes.
From robust Risk Adjustment Analytics, Retrospective Chart Reviews, Quality Reporting, Encounter Data Submissions, and Clinical Services, Episource starts with the smallest details and translates them to create better insights around patient disease profiles and care gaps.
Episource is headquartered in Gardena, California with additional operations in India and the Philippines. For more information on Episource, visit www.episource.com